Qrativ's Murali Aravamudan on "What's Possible" for AI in Drug Discovery

0 Anmeldelser
0
Episode
243 of 972
Længde
26M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

In this episode, we talk to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm reference. Murali and I discuss the surge of medical information and data in the medical industry, the role of artificial intelligence in developing drugs for treatments to various diseases, and the future of AI in drug discovery. For more in-depth interviews on the business applications of artificial intelligence, find us online at: www.TechEmergence.com


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036

Other podcasts you might like ...